We’re delighted to add our latest Educational Series on first-line treatment for unresectable stage III or IV melanoma.
The review covers the currently available first-line options for patients with advanced melanoma, with a focus on the recent evidence for use of ICIs in this patient population. It also includes guiding commentary from Associate Professor Matteo Carlino, a Medical Oncologist at Westmead and Blacktown Hospitals, and Clinical Associate Professor at The University of Sydney.
Please login below to download this issue (PDF)